Cellular Recognition and Repair of Monofunctional-Intercalative Platinum--DNA Adducts.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Chemical Research in Toxicology

• Publication date

  2015-10-16

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acs.chemrestox.5b00327PMID 26457537PMCID PMC4712070
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Design of enzymatically cleavable prodrugs of a potent platinum-containing anticancer agent.

  2014cited by this paper
• Robustness of DNA Repair through Collective Rate Control

  2014cited by this paper
• Investigating the cellular fate of a DNA-targeted platinum-based anticancer agent by orthogonal double-click chemistry

  2014cited by this paper
• Structural and mechanistic studies of polymerase η bypass of phenanthriplatin DNA damage

  2014cited by this paper
• Replication Checkpoint: Tuning and Coordination of Replication Forks in S Phase

  2013cited by this paper
• Using fluorescent post-labeling to probe the subcellular localization of DNA-targeted platinum anticancer agents.

  2013cited by this paper
• The Cell’s Nucleolus: an Emerging Target for Chemotherapeutic Intervention

  2013cited by this paper
• DNA metalating-intercalating hybrid agents for the treatment of chemoresistant cancers.

  2012cited by this paper
• Using a build-and-click approach for producing structural and functional diversity in DNA-targeted hybrid anticancer agents.

  2012cited by this paper
• Comparative chemogenomics to examine the mechanism of action of dna-targeted platinum-acridine anticancer agents.

  2012cited by this paper
• Synthesis, aqueous reactivity, and biological evaluation of carboxylic acid ester-functionalized platinum-acridine hybrid anticancer agents.

  2012cited by this paper
• Analysis of the DNA damage produced by a platinum-acridine antitumor agent and its effects in NCI-H460 lung cancer cells.

  2012cited by this paper
• Processing of anthracycline-DNA adducts via DNA replication and interstrand crosslink repair pathways.

  2012cited by this paper
• Competition, collaboration and coordination – determining how cells bypass DNA damage

  2012cited by this paper
• Mus81-mediated DNA cleavage resolves replication forks stalled by topoisomerase I–DNA complexes

  2011cited by this paper
• Inhibition of DNA Synthesis by a Platinum-Acridine Hybrid Agent Leads to Potent Cell Kill in Non-Small Cell Lung Cancer.

  2011cited by this paper
• Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair.

  2011cited by this paper
• Unusual Reactivity of a Potent Platinum-Acridine Hybrid Antitumor Agent.

  2011cited by this paper
• Rates of intercalator-driven platination of DNA determined by a restriction enzyme cleavage inhibition assay

  2011cited by this paper
• A minority of foci or pan-nuclear apoptotic staining of γH2AX in the S phase after UV damage contain DNA double-strand breaks

  2010cited by this paper
• Shortcomings of current therapies for non-small-cell lung cancer: unmet medical needs

  2009cited by this paper
• γH2AX and cancer

  2008cited by this paper
• ERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancer.

  2008cited by this paper
• A non-cross-linking platinum-acridine agent with potent activity in non-small-cell lung cancer.

  2008cited by this paper
• DNA repair in response to anthracycline-DNA adducts: a role for both homologous recombination and nucleotide excision repair.

  2008cited by this paper
• Structural and functional relationships of the XPF/MUS81 family of proteins.

  2008cited by this paper
• The resurgence of platinum-based cancer chemotherapy

  2007cited by this paper
• Trans-platinum complexes in cancer therapy.

  2007cited by this paper
• Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death.

  2006cited by this paper
• The structure‐specific endonuclease Mus81–Eme1 promotes conversion of interstrand DNA crosslinks into double‐strands breaks

  2006cited by this paper
• Cellular processing of platinum anticancer drugs

  2005cited by this paper
• Genome-Wide Requirements for Resistance to Functionally Distinct DNA-Damaging Agents

  2005cited by this paper
• Novel approaches towards development of non-classical platinum-based antineoplastic agents: design of platinum complexes characterized by an alternative DNA-binding pattern and/or tumor-targeted cytotoxicity.

  2005cited by this paper
• Protein interactions with platinum-DNA adducts: from structure to function.

  2004cited by this paper
• Polynuclear platinum drugs.

  2004cited by this paper
• Biophysical characterization and molecular modeling of the coordinative-intercalative DNA monoadduct of a platinum-acridinylthiourea agent in a site-specifically modified dodecamer

  2004cited by this paper
• DNA topoisomerase I-mediated nicking of circular duplex DNA.

  2001cited by this paper
• DNA-unwinding test using eukaryotic DNA topoisomerase I.

  2001cited by this paper
• DNA repair of pyrimidine dimers and 6-4 photoproducts in the ribosomal DNA.

  1999cited by this paper
• Efficient nucleotide excision repair of cisplatin, oxaliplatin, and Bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts.

  1999cited by this paper
• Nucleotide Excision Repair in Mammalian Cells*

  1997cited by this paper
• Repair of cisplatin--DNA adducts by the mammalian excision nuclease.

  1996cited by this paper
• Influence of cisplatin intrastrand crosslinking on the conformation, thermal stability, and energetics of a 20-mer DNA duplex.

  1996cited by this paper
• Photoreactivity of platinum(II) in cisplatin-modified DNA affords specific cross-links to HMG domain proteins.

  1996cited by this paper
• Lack of transcription-coupled repair in mammalian ribosomal RNA genes.

  1993cited by this paper
• Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts.

  1992cited by this paper
• An in vitro transcription analysis of early responses of the human immunodeficiency virus type 1 long terminal repeat to different transcriptional activators

  1991cited by this paper
• Mechanism of cis-diamminedichloroplatinum(II)-induced cytotoxicity: role of G2 arrest and DNA double-strand breaks.

  1988cited by this paper
• A high affinity topoisomerase I binding sequence is clustered at DNAase I hypersensitive sites in Tetrahymena R-chromatin.

  1985cited by this paper

• Short-Chain and Long-Chain Fatty Acid-Containing Platinum-Acridine Anticancer Prodrugs: Exploiting Alternative Mechanisms of Cellular Internalization.

  2026cites this paper
• Recent Advances in QSAR, SAR, and Therapeutic Potentials of Acridine Derivatives: A Review

  2025cites this paper
• The arylbipyridine platinum (II) complex increases the level of ROS and induces lipid peroxidation in glioblastoma cells

  2024cites this paper
• Salicylaldehyde-derived piperazine-functionalized hydrazone ligand-based Pt(II) complexes: inhibition of EZH2-dependent tumorigenesis in pancreatic ductal adenocarcinoma, synergism with PARP inhibitors and enhanced apoptosis.

  2024cites this paper
• Gastrointestinal cancer cells with Pt-resistance and relationship with aberrant expression of long non-coding RNAs

  2024cites this paper
• Platinum-Acridine Agents with High Activity in Cancers Expressing the Solute Carrier MATE1 (SLC47A1).

  2023cites this paper
• Chemosensitivity‐Gene Expression Correlations and Functional Enrichment Analysis Provide Insight into the Mechanism of Action of a Platinum‐Acridine Anticancer Agent

  2022cites this paper
• Computational and Experimental Characterization of rDNA and rRNA G-Quadruplexes.

  2022cites this paper
• DNA Adduct Detection after Post-Labeling Technique with PCR Amplification (DNA-ADAPT-qPCR) Identifies the Pre-Ribosomal RNA Gene as a Direct Target of Platinum-Acridine Anticancer Agents.

  2021cites this paper
• Valproic Acid Regulates HR and Cell Cycle Through MUS81-pRPA2 Pathway in Response to Hydroxyurea

  2021cites this paper
• Square-Planar vs. Trigonal Bipyramidal Geometry in Pt(II) Complexes Containing Triazole-Based Glucose Ligands as Potential Anticancer Agents

  2021cites this paper
• Mustards-Derived Terpyridine-Platinum Complexes as Anticancer Agents: DNA Alkylation vs Coordination.

  2021cites this paper
• Discovery of a Chiral DNA-Targeted Platinum-Acridine Agent with Potent Enantioselective Anticancer Activity.

  2020cites this paper
• A membrane transporter determines the spectrum of activity of a potent platinum–acridine hybrid anticancer agent

  2020cites this paper
• Computational investigation of possible inhibitors of the winged-helix domain of MUS81.

  2020cites this paper
• DNA topoisomerases as additional targets for anticancer monofunctional platinum(II) complexes.

  2020cites this paper
• A Membrane Transporter Determines the Spectrum of Activity of a Potent DNA-Targeted Hybrid Anticancer Agent

  2020cites this paper
• New platinum(II)-based DNA intercalator: Synthesis, characterization and anticancer activity

  2019cites this paper
• Application of the adverse outcome pathway framework to genotoxic modes of action

  2019cites this paper
• Effect of the nonleaving groups on the cellular uptake and cytotoxicity of platinum-acridine anticancer agents

  2019cites this paper
• MUS81 Participates in the Progression of Serous Ovarian Cancer Associated With Dysfunctional DNA Repair System

  2019cites this paper
• Palladium-Catalyzed Regioselective Alkoxylation via C-H Bond Activation in the Dihydrobenzo[c]acridine Series

  2018cites this paper
• DNA Repair Response Modulation Potentiates Low Dose Cisplatin Effects in HeLa Cells

  2018cites this paper
• Human Serum Albumin-Delivered [Au(PEt3)]+ Is a Potent Inhibitor of T Cell Proliferation.

  2017cites this paper
• The influence of the ethane-1,2-diamine ligand on the activity of a monofunctional platinum complex.

  2017cites this paper
• Tuning the Optical Properties of Phenanthriplatin: Towards New Photoactivatable Analogues

  2017cites this paper
• Enhanced anti-cancer efficacy to cancer cells by a novel monofunctional mononuclear platinum(II) complex containing a mixed S,N,S-donor ligand

  2017cites this paper
• Platinum Intercalators of DNA as Anticancer Agents

  2017cites this paper
• Large-Pore Functionalized Mesoporous Silica Nanoparticles as Drug Delivery Vector for a Highly Cytotoxic Hybrid Platinum-Acridine Anticancer Agent.

  2017cites this paper
• Anticancer Effects of a New Aminosugar-conjugated Platinum Complex Agent Against Cisplatin-resistant Gastric Cancer.

  2016cites this paper
• Investigating the cytotoxicity of platinum(II) complexes incorporating bidentate pyridyl-1,2,3-triazole "click" ligands.

  2016cites this paper
• Kinetic and Mechanistic Investigations on Some N,N-Chelated Pt(II) Oxalate Complexes with Some “S” Containing Biorelevant Ligands at Physiological Condition

  2016cites this paper
• Selective speciation improves efficacy and lowers toxicity of platinum anticancer and vanadium antidiabetic drugs.

  2016cites this paper
• ATM kinase inhibitor KU-55933 contribution in cisplatin mediated HeLa proliferation

  2016cites this paper